CytoMed Therapeutics Limited Adjustments For Depreciation And Amortisation Expense
CytoMed Therapeutics Limited (GDTC) reported Adjustments For Depreciation And Amortisation Expense of SGD 371.04 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense · last filed 2026-03-31
| Period end | Adjustments For Depreciation And Amortisation Expense 12 month |
|---|---|
| 2025-12-31 | 371.04K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 322.16K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 374.75K SGD 20-F · filed 2025-04-28 |
| 2022-12-31 | 379.67K SGD 20-F · filed 2024-04-22 |
| 2021-12-31 | 316.67K SGD 20-F · filed 2023-05-01 |